Dandapani-Savita

Savita Dandapani, M.D., Ph.D.

  • Assistant Professor, Department of Radiation Oncology
  • Radiation Oncologist

Savita Dandapani, M.D., Ph.D.

Clinical Specialties
  • Radiation Oncology
Areas of Expertise
  • Genitourinary Cancers
  • Radioimmunotherapy
  • Brain and Central Nervous System Tumors
  • Radionuclide Therapy
  • Stereotactic Radiosurgery
  • Stereotactic Body Radiation Therapy
  • Image-guided Intensity Modulated Radiation Therapy/TomoTherapy
  • Electronic Brachytherapy
Research Focus
  • Radiation Treatment for Lymphoma, Genitourinary and Brain Cancers
  • Radioimmunotherapy
  • Stereotactic Radiosurgery
Savita Dandapani, M.D., Ph.D., is a radiation oncologist who specializes in improving treatment outcomes and reducing side effects for cancer patients undergoing radiation therapy. She has been recognized numerous times for her clinical and research work in the topic, including a clinical cancer research award from the American Society of Clinical Oncology and a research award from American Association for Cancer Research.
 
Dr. Dandapani earned her doctoral and medical degrees from Harvard Medical School, respectively, and completed her radiation oncology residency at the University of Southern California.
  • 2013 - Present Assistant Professor, Department of Radiation Oncology, City of Hope, Duarte, CA
  • Genitourinary Cancers
  • Lymphoma
  • Brain Tumors
  • Pituitary Disorders

Locations

Duarte

1500 East Duarte Road, Duarte, CA, 91010

Get Directions

Phone :  626-256-4673

Degrees

  • 2008, M.A., M.D., Harvard Medical School, Boston, MA
  • 2006, M.A., Ph.D., Harvard University, Cambridge, MA
  • 2000, M.A., B.S., Massachusetts Institute of Technology, Cambridge, MA

Residency

  • 2009–2013 Resident, Radiation Oncology, University of Southern California, Los Angeles, CA

Internship

  • 2008–2009 Transitional Intern, Santa Clara Valley Medical Center, San Jose, CA
Information listed here is obtained from Pubmed, a public database; City of Hope is not responsible for its accuracy.
 
 
AW Browne, SV Dandapani, R Jennelle, M Stevanovic, TC Lee, AL Murphree, TD Kampp, MA Astrahan, JW Kim, JL Berry. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling. Brachytherapy. 2015, 14:718-725.
 
SV Dandapani, Y Zhang, R Jennelle, YG Lin. Radiation-associated toxicities in obese women with endometrial cancer: More than just BMI? Scientific World Journal 2015;483208 epub.
 
SV Dandapani, PM-Fauceglia, S Palmer, M Senikowich, YG Lin. Lower extremity pain as initial presentation of cervical cancer. Gynecologic Oncology Case Reports, August 2013, 5:13-15.
 
JL Berry, SV Dandapani, M Stevanovic, M Astrahan, AL Murphree, JW Kim. Outcomes of Medium-sized Choroidal Melanomas Treated with USC Eye Physics Plaques: 20 year review. JAMA Ophthamology. Nov 2013; 131(11):1435-42.
 
N Kamo*, SV Dandapani*, RA Miksad, MJ Houlihan, I Kaplan, M Regan, TK Greenfield, MG Sanda. Evaluation of the SCA instrument for measuring patient satisfaction with cancer care administered via paper or via the Internet. Annals of Oncology, March 2011, 22(3):723-9.
 
SV Dandapani, H Sugimoto, BD Matthews, RJ Kolb, S Sinha, RE Gerszten, J Zhou, DE Ingber, R Kalluri, MR Pollak. Alpha-actinin-4 is required for normal podocyte adhesion. Journal of Biological Chemistry 2007, January 5, 282(1), pp 467-77.
 
S Tonna, SV Dandapani, A Uscinski, GB Appel, JS Schlondorff, K Zhang, BM Denker, MR Pollak. Functional genetic variation in aminopeptidase A (ENPEP): Lack of clear association with focal and segmental glomerulosclerosis (FSGS). Gene 2008, February, 410(1), pp 44-52.
 
JM Henderson, S Al-Waheeb, A Weins, SV Dandapani, MR Pollak. Mice with altered alpha-actinin-4 expression have distinct morphologic patterns of glomerular disease. Kidney International 2008, January 9.
 
PO Humbert, C Rogers, S Ganiatsas, R Landsberg, JM Trimarchi, S Dandapani, C Brugnara, S Erdman, M Schrenzel, RT Bronson and JA Lees. E2F4 is essential for normal erythrocyte maturation and neonatal viability. Molecular Cell 2000, August, 6(2), pp 281-291.
 
PO Humbert, R Verona, J Trimarchi, C Rogers, S Dandapani and JA Lees. E2F3 is critical for normal cellular proliferation. Genes & Development 2000, March 15, 14(6), pp 690-703.

Publications (review articles)

SV Dandapani, M Eaton, CR Thomas, PG Pagnini. HIV-positive anal cancer: An update for the clinician. Journal of Gastrointestinal Oncology. August 2010, 1(1):34-44.
 
SV Dandapani and MG Sanda. Measuring health-related quality of life consequences from primary treatment for early stage prostate cancer. Seminars in Radiation Oncology 2008, January 18(1), pp 67-72.
 
SV Dandapani, MR Pollak. The glomerular filter: biologic and genetic complexity. Kidney International 2006, September, 70(6), pp 980-982.
 
Book Chapters
 
SV Dandapani and J Wong. Chapter 16 Radioimmunotherapy. In Antibody-Drug Conjugates: Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer. Editors: Kenneth Olivier and Sara A Hurvitz. November 2016.
 
SV Dandapani. Chapter Biomarkers and Radiotherapy. In Advances in Radiation Oncology. Editor: Jeffrey Wong. April 2017.
 
JYC Wong, S Hui, SV Dandapani, A Liu. Chapter Biologic and Image Guided Systemic Radiotherapy. In Advances in Radiation Oncology. Editor: Jeffrey Wong. April 2017.
 
Published Abstracts
 
JC Yang1, Anita Kumar2, Katherine L. Chapman3, Sarah Burleson3, Chi Huang3, Louis S. Constine4, Richard T. Hoppe5, Savita V. Dandapani6, David J. Straus2, Craig H. Moskowitz2, and Joachim Yahalom. Dose and/or Volume Reduction Using Consolidation Volume Radiation Therapy (CVRT) Lowers Dose to Heart and Lungs in Early-Stage Hodgkin Lymphoma Patients with Bulky Disease. Submitted to International Lymphoma Conference on malignant lymphoma, Lugano 2017.
 
Anita Kumar1, Carla Casulo2, Ranjana Advani3, Elizabeth Budde4, Paul M. Barr2, Connie L. Batlevi1, Philip Caron1, Robert Chen4, Louis S. Constine2, Amanda Courtien1, Savita V. Dandapani4, Pamela Drullinsky1, Jonathan W. Friedberg2, John F. Gerecitano1, Audrey Hamilton1, Paul A. Hamlin1, Richard T. Hoppe3, Steven M. Horwitz1, Matthew J. Matasar1, Gianna N. McArthur1, Shoshana T. Miller1, Alison J. Moskowitz1, Ariela Noy1, Maria L. Palomba1, Carol S. Portlock1, Heiko Schöder1, David J. Straus1, Joanna Yang1, Anas Younes1, Andrew D. Zelenetz1, Zhigang Zhang1, Joachim Yahalom1, and Craig H. Moskowitz. A Pilot Study of Brentuximab Vedotin and AVD Chemotherapy followed by 20 Gy Involved-Site Radiotherapy in Early Stage, Unfavorable Risk Hodgkin Lymphoma. Submitted to International Lymphoma conference on malignant lymphoma, Lugano 2017.
 
SV Dandapani, A Kazarian, J Hsu, NL Vora, L Vora, A Liu, SK Pal. Safety and Efficacy of radiotherapy concurrent with VEGF- and mTOR- inhibitors in metastatic renal cell carcinoma. ASTRO 2016.
 
SV Dandapani, Y Zhang, R Jennelle, YG Lin. Radiation-associated toxicities in obese women with endometrial cancer: More than just BMI? American Radium Society (ARS) Oncology 2015 April 21;29(4 Suppl 1).
 
SV Dandapani, C Nguyen, F Hofman, T Chen, HJ Lenz, M Kahn, CK Hill, PG Pagnini. Potential Role of Novel Wnt Modulator ICG-001 As A Radiosensitizer In Glioblastoma Cell Lines. ASTRO October 2012.
 
SV Dandapani, JL Berry, AL Murphree, M Astrahan. The USC Experience In Treating Medium Sized Choroidal Melanomas With Eye Physics Eye Plaque Brachytherapy (125-I). ASTRO October 2012.
 
E Wu, SV Dandapani, A Rogers, J Yoo, L Ji, R Sposto, A Yessaian, H Pham, AS Lee, P Fauceglia, YG Lin. Endoplasmic Reticulum Stress Induction and Response to Chemoradiation in Cervical Cancer. Society for Gynecological Oncology (SGO) 2012.
 
SV Dandapani, PG Pagnini. Cyberknife radiosurgery is safe and effective for meningiomas near the optic apparatus: the USC experience. ASTRO October 2011.
 
PG Pagnini, SV Dandapani, HJ Lenz, M Kahn, C Hill, T Chen, D Yang, M Press. Phase I/II Trial of a novel stem cell drug, PRI-724 in newly diagnosed glioblastoma multiforme (GBM). Whittier Foundation Presentation April 2011.
 
SV Dandapani, JJ Kang, JC Felix, JE Shriki, PG Pagnini. Prognostic Role of Pathologic Complete Response to Neoadjuvant Chemoradiation in FIGO IB2 Cervical Cancer. ASTRO October 2010. Los Angeles Radiological Society annual meeting January 2010. Oncology Practice Reviews Meeting March 2010.
 
SV Dandapani. MR Pollak. Podocyte detachment from matrix in α-actinin-4 mediated kidney disease. Massachusetts Medical Society 2006.
 
SV Dandapani, H Sugimoto, BD Matthews, DE Ingber, R Kalluri, MR Pollak. Podocyte loss in Alpha-actinin-4 mediated glomerular disease. American Society for Nephrology Annual Meeting, September 2005. American Society for Cell Biology 2005.
 
SV Dandapani, Yi Li, H Varmus. Modeling Cancer Using an Avian Retroviral Gene Delivery System. NIH Presentation Day 1999.
 
  • American Society for Therapeutic Radiology and Oncology
  • American Association for Cancer Research
  • American Society of Clinical Oncology
  • Radiological Society of North America
  • American College of Radiology
  • Radiation Therapy Oncology Group
  • American College of Radiation Oncology
  • American Brachytherapy Society
  • 2012, ASTRO/AANS Stereotactic Radiosurgery Course
  • 2011, American Society for Clinical Oncology Award, Clinical Cancer Research, Vail, CO
  • 2011, AACR Research Award, Molecular Biology in Clinical Oncology, Aspen, CO
  • 2007, Massachusetts Medical Society Research Award
  • 2005, Invited Presentation, American Society for Nephrology
  • 1999, National Institutes of Health Summer Research Program
  • 1996 Robert C. Byrd Scholarship
Back To Top